About Icon Bioscience
Icon Bioscience is a company based in Sunnyvale (United States) founded in 2004 was acquired by EyePoint Pharmaceuticals in March 2018. Icon Bioscience has raised $37.32 million across 3 funding rounds from investors including EyePoint Pharmaceuticals. Icon Bioscience offers products and services including Prescription Medications and Online Pharmacy Services.
- Headquarter Sunnyvale, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name My Canadian Pharmacy
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$37.32 M (USD)
in 3 rounds
-
Latest Funding Round
$5.32 M (USD), Series B
Dec 01, 2015
- Investors
-
Employee Count
Not available
-
Acquired by
EyePoint Pharmaceuticals
(Mar 28, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Icon Bioscience
Icon Bioscience offers a comprehensive portfolio of products and services, including Prescription Medications and Online Pharmacy Services.
Various prescription drugs are sold for conditions such as erectile dysfunction and asthma.
Services including prescription refills and transfers are offered to support customer access to medications.
Funding Insights of Icon Bioscience
Icon Bioscience has successfully raised a total of $37.32M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $5.32 million completed in December 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Icon Bioscience
Icon Bioscience has secured backing from 1 investor. Prominent investors backing the company include EyePoint Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Small molecule therapeutics for ophthalmic disorders are developed.
|
Locked | Locked | Locked |
Investor details for Icon Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Icon Bioscience
Investment portfolio details for Icon Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Icon Bioscience
Detailed financials for Icon Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Icon Bioscience Comparisons
Peer comparison for Icon Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Icon Bioscience
Detailed competitors of Icon Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Icon Bioscience
Complete news archive for Icon Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Icon Bioscience
Icon Bioscience was founded in 2004 and raised its 1st funding round 9 years after it was founded.
Icon Bioscience is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Icon Bioscience is a funded company, having raised a total of $37.32M across 3 funding rounds to date.
Icon Bioscience was established in 2004 in Sunnyvale, United States, operating as an online pharmacy in the healthcare sector. Medications for conditions such as erectile dysfunction, birth control, asthma, and pain relief are sourced directly from manufacturers with emphasis on quality control and proper storage. Existing prescriptions can be transferred or refilled by customers, including as guests, while a search function aids product location. Pharmacist consultations are available for inquiries.
Icon Bioscience offers Prescription Medications and Online Pharmacy Services.
Icon Bioscience has 1 investor. Key investors include EyePoint Pharmaceuticals.